ArQule Inc: Premium Company Profile

Questions: Discounts, Updates etc.

Price: $495.00

Publication Date: 2008-01-01

Order Online Now

People that purchased this report also purchased:

Contact LeadDiscovery

  • If you have questions about this report
  • To find out if you qualify for a discount
  • Want a more up to date version
  • Can't find a report that meets your needs
Search all reports

Keywords:

Boolean terms AND, OR, NOT can be used. Phrases should be entered within quotes. For wildcards use an *

ArQule, founded as a chemistry service company, became a drug discovery and development company by acquiring Cyclic Pharmaceuticals in 2003. The company's proprietary drug discovery platforms such as Cancer Survival Pathways and Activated Checkpoint Therapy have helped it building a product pipeline.


Scope

  • Contains corporate strategy, value chain presence and SWOT Analysis
  • Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors
  • Includes information on suppliers/ partners, shareholding structure and key employees with biographies

  • Report Highlights
    ArQule is a biotechnology company engaged in the research and development of next-generation, small-molecule cancer therapeutics. It's product pipeline includes: ARQ 501 in Phase II for sarcoma, head and neck cancer and pancreatic cancer; ARQ 171 in Phase I for cancer; and ARQ 197 in Phase II for the treatment of solid tumors and pancreatic cancer.

    The company recognizes revenues in the form of collaboration fees and milestone payments from the companies with which it has entered into collaboration agreements with Roche and Wyeth.

    The company's total revenues increased during 2004-2006, from $5 million to $6.6 million. The company's only contributor to revenue growth during 2004-2006 was revenues received under license and collaboration agreements with Roche and Wyeth.


    Reasons to Purchase

  • Access all the important information and analysis on the company in a single report
  • Understand company's strengths, weaknesses, opportunities and threats along with business strategy and value chain
  • Gain access to company's adjusted five year financial data along with key ratios and market capitalization
  • Table of Contents

    Other users found this report page using the following search terms: structure 197 arq arqule chemical messina arq197 telephone s ion

    If you can't find a report that meets your needs contact LeadDiscovery. We are one of the few report providers with extensive drug development experience and we frequently use this knowledge to help clients source the most appropriate reports or produce reports for them from scratch.


    Refund and Cancellation Policy: The descriptions of the products and services sold on LeadDiscovery.co.uk are as complete and accurate as possible, and customers are encouraged to read all available information about a product before placing an order. Due to the nature of the information being sold, orders for reports cannot be canceled.